EPIVONY
"EPIVONY" is a word mark owned by Helus Pharma Corp., filed at the USPTO on October 26, 2026. It is under examination and covers classes 1, 5 and 42.
- Status
- Under examination
- Since October 26, 2026
- Filed
- October 26, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50182205
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns EPIVONY
The owner and representative on file with the office.
Owner
Helus Pharma Corp.
Toronto, Canada
Representative
Kimberly Bullock Gatling
Fox Rothschild LLP
What the mark covers
The products and services EPIVONY is filed for, grouped by Nice class.
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders
Pharmaceutical preparations for the treatment of mental health disorders, including neurological conditions and psychiatric conditions;; Pharmaceutical preparations for the treatment of mental health disorders, including depression and anxiety
Pharmaceutical drug development services
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About EPIVONY
Who owns the trademark "EPIVONY"?
The USPTO trademark "EPIVONY" (application 50182205) is owned by Helus Pharma Corp.
What is the status of "EPIVONY"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull EPIVONY and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a17d7a-e600-7526-b85b-b99c1ffa65f8
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a17d7a-e600-7526-b85b-b99c1ffa65f8",
"object": "trademark",
"mark_text": "EPIVONY",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50182205",
"filing_date": "2026-10-26",
"nice_classes": [
1,
5,
42
],
"owners": [
{
"name": "Helus Pharma Corp.",
"entity_id": null
}
]
}